Drug search by name

Epoetin Alfa Vials and Seizures

Result of checking the interaction of drug Epoetin Alfa Vials and disease Seizures for safety when used together.

Check result:

Epoetin Alfa Vials <> Seizures

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of erythropoiesis stimulating agents increases the risk of seizures in patients with chronic renal failure. Seizure development may be related to the rate of rise in hematocrit, which is also associated with blood pressure elevations. It is recommended to monitor patients closely for the development of premonitory neurologic symptoms during the first several months after the administration of these agents. Patients with epilepsy or predisposed to seizures should be monitored closely for blood pressure changes and neurologic symptoms during therapy with these agents.

References:

"Product Information. Epogen (epoetin alfa)." Amgen, Thousand Oaks, CA.
Bennett WM "Side effects of erythropoietin therapy." Am J Kidney Dis 18 (1991): 84-6
Singbartl G "Adverse events of erythropoietin in long-term and in acute short-term treatment." Clin Investig 72 (1994): s36-43
Temple RM, Eadington DW, Swainson CP, Winney R "Seizure related to erythropoietin treatment in patients undergoing dialysis." BMJ 300 (1990): 46
Beccari M "Seizures in dialysis patients treated with recombinant erythropoietin - review of the literature and guidelines for prevention." Int J Artif Organs 17 (1994): 5-13
"Product Information. Procrit (epoetin alfa)." Ortho Biotech Inc, Raritan, NJ.

Epoetin Alfa Vials

Generic Name: epoetin alfa

Brand Name: Epogen, Procrit, Retacrit

Synonyms: Epoetin alfa, Epoetin Alfa

What is Epoetin Alfa Vials?